Marketresearchnews

Tuesday 24 August 2021

New research report offers detailed research on developments in Microtome Market 2027

Market Analysis

Microtomes are instruments used in the cutting of materials into thin slices known as sections. The accuracy of these sections can assist laboratories in determining and diagnosing the cause of the disease in biopsies. Market Research Future’s (MRFR) report on the global microtome market contains a summary of the drivers, restraints, trends, and opportunities for the period of 2019 to 2025 (forecast period).

Market Outlook

The global microtome market is touted to reach a valuation of USD 120 million by 2025. It is expected to exhibit a CAGR of 6.1% over the forecast period. Prevalence of chronic diseases is the primary driver of the market. Tissue samples are required in research laboratories for identifying the presence of cancerous cells in the body. According to the World Health Organization (WHO), close to 3.7 million cases of cancer are detected annually in Europe.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8568

The growing numbers of the elderly and availability of new diagnostic techniques can fuel the growth opportunities of the global microtome market. Approvals of new products and subsequent launches can bode well for the market. For instance, Leica Biosystems added a new line of microtomes to its product offerings.

However, lack of skilled personnel in operating the equipment can hamper the market growth.

Segmentation

The global microtome market is segmented by product, technology, application, and end user.

By product, it is bifurcated into two sub-segments, instruments and microtome accessories. Instruments comprise cryostat microtomes, vibrating microtomes, rotary microtomes, and other microtomes. The instruments segment is expected to hold the major market share owing to availability of these systems and their ease in handling. Within the instruments segment, cryostat microtomes are used in sectioning tissue samples free of ice crystal defects and operated in a deep freeze cabinet. Rotary microtomes hold the distinction of being heavier and stable than rocking microtomes and being able to cut serial sections. This segment can register the highest growth rate during the forecast period. Vibrating microtomes, on the other hand, are used in slicing sections of animals and plants.

By technology, it is segmented into manual, semi-automatic microtomes, and full-automatic microtomes. Full-automatic microtomes have held the market dominance owing to demand for systems with high precision.

By application, it is divided into medical research and disease diagnosis. The disease diagnosis segment accounted for the largest market share owing to increasing number of tissue examinations in hospitals and research laboratories. Benefits of early diagnosis of diseases at a preventive stage are expected to drive segment growth during the forecast period.

By end user, it is divided into diagnostic laboratories and hospital laboratories. Hospital laboratories are dominating the global microtome market. This can be attributed to huge volume of tissue examinations performed in hospital labs.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are regions covered in the global microtome market.

The Americas is the largest market owing to presence of prominent market leaders, prevalence of cancer, need for biopsies, and a large patient population. This is buttressed by the report of National Cancer Institute which registered apparently 1,735,350 cases of cancer in the United States.

Europe is estimated to exhibit a robust growth rate during the forecast period owing to demand for advanced diagnostic tools and presence of reputed players in the pharmaceutical industry. Initiatives by governments to encourage adoption of these tools can benefit the global microtome market greatly.

Competition Outlook

Kronus, Biomérieux, Qualigen, Diasorin, Merck, Danaher, Abbott, Roche, Autobio Diagnostics, Diagnostic Automation/Cortez Diagnostics, and Thermo Fisher are prominent names in the global microtome market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microtome-market-8568

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

New research report offers detailed research on developments in Menopause Treatment Market 2027

Market Analysis

The global menopause treatment market is likely to touch USD 15, 456.3 million at a 6.18% CAGR between 2020- 2027, according to the new report by Market Research Future (MRFR). Menopause, simply put, is the time that marks the end of a woman’s menstrual cycle. This is diagnosed when a woman has missed a menstrual period for 12 months. Some of the common symptoms of this natural biological process include hot flashes, vaginal dryness, and at times sleep disturbances.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4579

Market Drivers and Restraints

Various factors are adding to the global menopause treatment market growth. According to the new MRFR report, such factors include burgeoning demand for personalized medication to cure menopause symptoms, the proliferation of gynecology centers and healthcare facilities, increasing awareness about women's health, increasing product launches, and growing older female population.

On the contrary, side effects like breast cancer, strokes, heart attacks, and blood clots from hormonal treatments may limit the global menopause treatment market growth over the forecast period.

Market Segmentation

The MRFR report gives an inclusive segmental analysis of the global menopause treatment market report based on distribution channels and treatment.

By treatment, the global menopause treatment market is segmented into non-hormonal and hormonal treatment. The hormonal treatment is again segmented into progesterone, estrogen, and combination. The non-hormonal treatment is segmented into anti-depressants, and others. Of these, the hormonal treatment will lead the market over the forecast period as it is the most commonly prescribed medications. Its ability to alleviate vaginal dryness and menopausal hot flashes symptoms are adding to the growth of the segment.

By distribution channel, the global menopause treatment market is segmented into online stores, retail pharmacies, and hospital pharmacies. Of these, the hospital pharmacies will dominate the market over the forecast period. Growing awareness about menopausal treatment, increased uptake, and growing women population, especially in developed countries, is adding to the growth of the segment.

Regional Analysis

Based on the region, the global menopause treatment market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), and & Middle East and Africa (MEA). Among these, the Americas is predicted to dominate the market over the forecast period. A growing number of geriatric women, coupled with the rising number of product launches, are adding to the global menopause treatment market growth in the region. The US has the maximum share in the region. About six thousand women in the US reach menopause daily in the US.

The global menopause market in Europe is predicted to have the second-largest share over the forecast period. The presence of developed healthcare infrastructure in European countries, new product launches, and the growing prevalence of urogenital complications and vasomotor symptoms in women are adding to the global menopause market growth in the region.

The global menopause treatment market in the APAC region is predicted to grow at a high CAGR over the forecast period. Prominent players joining hands with regional distributors and vendors, coupled with increasing awareness about women’s health are adding to the global treatment market growth in the region.

The global menopause treatment market in the MEA is predicted to have sound growth over the forecast period. The high adoption rate of menopause therapies in Saudi Arabia, the UAE, and South Africa is adding to the global menopause treatment market growth in the region. On the other hand, social stigma in women about menopause may hinder market growth to some extent.

Key Players

Prominent players profiled in the global menopause treatment market report include Abbott Laboratories (US), Merck & Co., Inc. (US), Teva Pharmaceuticals (Israel), Cipla Inc. (India), Novartis AG (Switzerland), Emcure Pharmaceuticals Ltd (India), Eli Lily and Company (US), Allergan (Ireland), Pfizer Inc. (US), and Novo Nordisk A/S (Denmark).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Nebulizers Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

Market Scenario

According to MRFR analysis, the Global Nebulizers Market is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027.

A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine.

The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9586

Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period.

However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market.

Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User.

Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers.

On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users.

Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use.

The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players

Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nebulizers-market-9586

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Electronic Trial Master File (eTMF) Systems Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2027

Market Scenario

According to MRFR analysis, Global eTMF Systems Market is expected to register a CAGR of 13.11% during the forecast period of 2019 to 2025 and anticipated to reach USD 1,825 Million by 2025.

The eTMF serves as a central repository to store and manage essential clinical trial documents and content for possible use in regulatory submissions. The eTMF software streamlines agency compliance with standards-based exports, and eSubmissions enables sharing between clinical trial stakeholders with language-independent taxonomy.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8772

The growth of the global eTMF systems market is fueled by several factors such as rising activities in terms of acquisitions, new solution and service deployments, and collaborations by key players operating in the market, coupled with the increasing number of clinical trial studies. For instance, in October 2019, SureClinical Inc. launched a transparent eTMF pricing policy. To provide value to the prospective users, the company has posted its prices and terms online to battle price discrimination in this industry. However, budget constraints of the small and medium-sized enterprises, along with the dearth of skilled professionals for operating the electronic systems, can hinder the preference of such solutions. As a result, such elements can hamper the growth of the market during the forecast period.

Several market players currently dominate the global eTMF systems market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Phlexglobal, a UK-based specialist provider of TMF and eTMF management solutions, is adopting Version 1 of the eTMF Exchange Mechanism Standard (eTMF-EMS) of the TMF Reference Model (TMF-RM) into PhlexEview, the company’s eTMF technology. Such strategies push the growth of the eTMF systems market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada. The eTMF systems market in the Americas has been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European eTMF systems market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The eTMF systems market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The eTMF systems market in this region is anticipated to be the fastest-growing during the assessment period due to the increased adoption rate of eTMF software and services in the Asian countries. The eTMF systems market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global eTMF Systems Market has been segmented based on Component, Deployment Mode, and End User.

The global eTMF systems market has been segmented, based on the component, into software and services. The software segment is expected to hold the majority share of the market owing to the increasing number of solution launches by the prominent players in recent years. The services segment is expected to be the fastest-growing due to the increasing uptake of eTMF services by pharmaceutical and life science companies.

The global eTMF systems market, based on deployment model, has been segmented into cloud/web-based, and on-premise. The cloud/web-based segment holds the maximum share owing to the technological advancements in cloud-based solutions in recent years.

The end-users of the market are pharmaceutical and biotechnology companies, contract research organizations, and others. The increasing number of clinical trials conducted by pharma firms is leading to the market size of the pharmaceutical and biotechnology companies’ segment.

Key Players

Some of the Key Players in the Global eTMF Systems Market are Aurea, Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US), Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva Systems (US), and Wingspan (IQVIA) (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/etmf-systems-market-8772

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Avian Influenza Vaccine Market Growth, Trends and Value Chain 2020-2027

Market Scenario

Avian influenza or bird flu is a virus which affects wild and domestic birds such as geese, duck, chicken, and turkeys. Some strains of the virus have a potential of creating a pandemic similar to the COVID-19 virus and can be transmitted to humans. The global avian influenza vaccine market report by Market Research Future (MRFR) stresses on the developments in vaccines, clinical trials, and its potential for the period of 2019 to 2025 (forecast period). It also touches on the impact of the COVID-19 virus on the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8769

Market Scope

The global avian influenza vaccine market size is predicted to reach USD 735.22 million by 2025. It can garner revenues at 7.25% CAGR over the forecast period. Large cases of avian diseases are one of the biggest drivers of the market. The sudden outbreak of avian flu in 2008 has culminated in culling of birds on a large scale. In order to avoid a repeat of the incident, vaccine manufacturers are investing in research and development to create possible vaccines for various strains of the H5N1 virus. This is exemplified by the license conferred to Sanofi Pasteur by the U.S. FDA for the H5N1 vaccine.

Rising investments in poultry farms due to the increasing gravitation towards protein by consumers can boost the global avian influenza vaccine market demand. Researchers at Kansas University had collaborated with Icahn School of Medicine for development of a vaccine against strains of bird flu. Development of live vaccines for enhancing the immunity of birds against germs and bacteria can bode well for the market.

Segmentation

The global avian influenza vaccine market has been segmented by strain and application.

The market, based on strain, has been segmented into H5, H7, and H9.

Based on application, the avian influenza vaccine market has been segmented into goose & duck, chicken, and turkey.

Regional Analysis

The global avian influenza vaccine market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.

The APAC & Middle East is likely to dominate the global avian influenza vaccine market. This can be attributed to the increasing production of poultry and the subsequent rise in avian influenza outbreaks in the region. According to a recent report from the Foreign Agricultural Service/USDA, China had registered 13,800 thousand metric tons of chicken meat production in 2019. Furthermore, various government initiatives for rapid and effective response for zoonotic diseases can augur favorably for the market.

Europe is estimated to be the second-largest region during the review period. The growing dependence on poultry for protein and presence of various biotechnology firms for production of vaccines can influence the regional market growth. According to the European Commission, the European Union (EU) produced 15.2 million tons of poultry meat in 2018. Rise of veterinary clinics and production of meat can both evoke massive demand in the global avian influenza vaccine market.

The Americas is estimated to demonstrate significant market growth owing large number of veterinarian clinics, investment in healthcare, and focus on animal health. According to the North American Meat Institute, the US exported 3.7 million metric tons (MT) of poultry and poultry variety meats in 2017. This is expected to accelerate the demand for avian influenza vaccines among the populace. Recently, a cell-based vaccine, Audenz, by Seqirus has been approved by the U.S. FDA for use among children 6 and older.

Competition Outlook

JOVAC, Avimex Animal Health, Guangdong Wenshi Dahuanong Biotechnology Co., Ltd, Medion, Zoetis, Tianjin Ringpu Bio-Technology Co., Ltd, QYH BIOTECH COMPANY LIMITED, Boehringer Ingelheim International GmbH, CAVAC, PT Japfa Comfeed Indonesia Tbk, Chengdu Tech-bank Biological Products Co., Ltd, Merck Animal Health, Ceva, FATRO S.P.A., and Yebio Bioengineering Co., Ltd, are key players of the global avian influenza vaccine market.

Strategic agreements are witnessed in the global market as public and private agencies are investing in the animal husbandry sector. Corporations are collaborating in creating educational programs for veterinarians and promoting animal health.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Interventional Cardiology Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

Market Scenario

The burgeoning number of cases related to heart ailments is estimated to promote the expansion of the interventional cardiology market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is estimated to demonstrate a 7.25% CAGR in the duration of the forecast period.

The advancement in healthcare facilities and procedures is estimated to create a promising scope for progress in the interventional cardiology market. The improved funding programs in the global market are predicted to reinforce the interventional cardiology market positively.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8735

Segmental Analysis

The segmental overview of the interventional cardiology market is carried out on the basis of type, end user, and regions. The type segment of the interventional cardiology market consists of plaque modification devices, coronary guidewires, accessories, stents which further includes bare metal stents, drug-eluting stents, and bioresorbable vascular scaffolds, percutaneous transluminal coronary angioplasty (PTCA) catheters such as balloon catheters and guiding catheters. The region segment of the interventional cardiology market consists of Europe, the Americas, Asia-Pacific, and the Middle East & Africa. The end-user segment of the interventional cardiology market consists of cardiac catheterization laboratories, hospitals, and ambulatory surgical centers.

Regional Overview

The regional assessment of the interventional cardiology market consists of Europe, the Americas, Asia-Pacific, and the Middle East & Africa. The Americas interventional cardiology market was the major regional market in 2018 due to the augmented cases of coronary diseases in this region. Percutaneous coronary intervention is one of the two most common practices executed on patients with coronary artery disease in the U.S. The European region's interventional cardiology market holds the next principal share due to an augmented number of hospitalizations for practices such as cerebral angioplasty and carotid artery angioplasty. The Asia Pacific region's interventional cardiology market is foreseen to be the fastest mounting region in the global market. The producers' advantageous marketing initiatives are performing a considerable role in growing the target audience and consequently growing the Interventional cardiology market size in this region. Similarly, the upsurge in the setups of research and development hubs and the increase in the number of collaborations are driving the growth of the interventional cardiology market in this region.

Competitive Analysis

The development of novel production processes is likely to enhance market strength further. The stabilization of demand and supply forces is estimated to open up opportunities for expansion in the forecast period. The market is estimated to derive momentum from improvement in operating systems within the market. As the market players understand the advantages of a lean operation framework, the market is estimated to transform considerably. The role of the government bodies in almost every country is estimated to be valuable to restore normalcy and create a growth outlook. The forging of novel international trade relations is estimated to bolster the market's capabilities in the upcoming period. The fast-paced adoption of online services and selling platforms is estimated to reinforce market progress in the upcoming years. The consolidation of market competition is predicted to usher in a new development phase in the impending period. The earmarked budget for innovation is set to rise with companies realizing the impact of having a progressive product assortment.

The distinguished companies in the interventional cardiology market are Abbott (U.S.), Cook Medical (U.S.), Life Vascular Devices Biotech S.L. (Spain), ACIST Medical Systems, Inc. (the U.S.), B.D. (U.S.), Boston Scientific Corporation (U.S.), Biotronik SE & Co. K.G. (Germany), Cardinal Health (U.S.), Medtronic (Ireland), Edwards Lifesciences Corporation (U.S.), G.E. Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), ABIOMED (U.S.), Biosense Webster, Inc (U.S.), Merit Medical Systems, Inc (U.S.), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), and W. L. Gore & Associates, Inc. (U.S.).

Industry Updates:

May 2021 A partnership of the University of South Florida's Health Interventional Cardiology Group and Tampa General Hospital (TGH) have accepted a novel intravascular imaging technology and completed the first such technique in the world. The novel intravascular technology, named High-Frequency Optical Coherence Tomography (HF-OCT), was lately performed on a patient with serious coronary artery disease, which was the primary such fruitfully treated in the world. Tampa General has been an initial adopter of intravascular imaging for coronary intervention and persists in seeking the latest and finest technology. The team has combined intravascular ultrasound (IVUS) and intravascular optical coherence tomography to see inside the blood vessels.

May 2021 Abbott recently announced its novel interventional imaging platform driven by Ultreon 1.0 Software, which acquired a European C.E. mark. This first-of-its-kind imaging software combines optical coherence tomography (OCT) intravascular imaging with the control of artificial intelligence (A.I.) for improved visualization. The novel Ultreon Software can automatically notice the seriousness of calcium-based blockages and gauge vessel diameter to improve the exactness of physicians' decision-making throughout coronary stenting procedures.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/interventional-cardiology-market-8735

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pharmacovigilance Market to Witness Widespread Expansion During 2020-2027

Market Scenario

Market Research Future (MRFR) studied the global pharmacovigilance market 2021 for the assessment period till 2025. MRFR assessment study reveals that the global pharmacovigilance market is anticipated to register 14.1% CAGR and earn value USD 4321.86 Mn by 2025.

Drivers and Restrains Impacting Pharmacovigilance Market Growth

Pharmacovigilance supports the safe and appropriate use of drugs and contribute to the identification of risk factors involved in the development and administration of adverse drug reactions (ADR). The need to for detecting unknown ADR is expected to support the growth of the pharmacovigilance market in the near future. The expansion of the pharmacovigilance market can also be attributed to the presence of well-established players involved in the design, development, and launching of products with strategic collaborations to strengthen their global presence. For instance, Accenture, an Ireland-based MNC service provider and consulting company, launched INTENT to enhance the continuity and flow of data across different life sciences enterprises that can supporting the delivery of effective treatments for patients.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6267

Segment Analysis of Pharmacovigilance Market

The segment analysis of the global market of pharmacovigilance is done on the basis of clinical trial phase, end-user, service provider, and type.

The clinical trial phase-based segments of the of pharmacovigilance market are phase IV, phase II, phase III, pre-clinical, and phase I. The segment of Phase IV is expected to churn-up considerable revenue for the pharmacovigilance market owing to adverse drug reactions that can be detected in this phase. The segment of the phase III is likely to expand at high pace over the review tenure.

The service provider-based segments of the global market of pharmacovigilance market are contract outsourcing and in-house. The segment of contract outsourcing can acquire high revenue in the near future. The rise of the pharmacovigilance market can be attributed to the increase in number of contract manufacturing dedicated to serve multiple customers, acquiring raw materials at affordable prices to allow economic benefits.

The type-based segments of the global market of pharmacovigilance are spontaneous reporting, intensified ADR reporting, cohort event monitoring, EHR mining, and targeted spontaneous reporting. The segment of spontaneous reporting can hold the highest share of the global market owing to its passive approach to pharmacovigilance and its reliance on the motivation of patients to report suspected ADRs to any national or local pharmacovigilance center.

The end-user-based segments of the global pharmacovigilance market are hospitals, pharmaceutical companies, and research organizations among others. The segment of hospitals is expected to contribute considerably to the market upsurge owing to rise in number of hospital admissions from ADRs.

Regional Analysis of Pharmacovigilance Market

The market of pharmacovigilance is studied for key regions; the Americas, Europe, Asia Pacific, and the Middle East Asia and Africa to gain regional insights into the market. In the Americas the pharmacovigilance market rise can be attributed to the high expense on pharmaceutical industry. The study of the pharmacovigilance market in the Americas is done for Latin America and North America. North America pharmacovigilance market is assessed for the US and Canada. In Europe, the study of the market of pharmacovigilance is done for the Eastern Europe and the Western Europe. The regional assessment of the Western European is done across the UK, Germany, Italy, France, and Spain, along with the rest of Western Europe. In the Asia Pacific, the market of pharmacovigilance is studied for Japan, China, Australia, and the other regions of Asia Pacific to learn about demographic and geographic factors that is expected to influence the regional market in the region. The increasing increasing prevalence of infection and chronic conditions in the regions of APAC that has resulted due to adverse reaction of drugs and other medication errors can contribute to the regional market expansion. Asia Pacific market can thrive owing to the gradual increase in research and development in the large number of research organizations that are present. In the Middle East Asia and Africa region, the market of pharmacovigilance is likely to rise at a steady pace.

Pharmacovigilance Market Key Players

Accenture (Ireland), BioClinica (US), ArisGlobal (US), Capgemini (France), Cognizant (US), IBM Corporation (US), Conquest Group BV (Netherlands), ICON PLC (Ireland), ITClinical (Portugal), IMEDGlobal (US), Laboratory Corporation of America Holdings (US), TAKE Solutions Ltd (India), United BioSource Corporation (US), PAREXEL International Corporation (US), and Wipro Ltd (India) are some reputed companies in the pharmacovigilance market that are listed by MRFR in the report.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pharmacovigilance-market-8451

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com